Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline UpdateDavendra P S Sohal, Erin B Kennedy, Alok Khorana, et al.
Cancer Research Communications|March 27, 2023
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the PancreasManuel Hidalgo, Rocio Garcia-Carbonero, Kian-Huat Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2020
Metastatic Pancreatic Cancer: ASCO Guideline UpdateDavendra P S Sohal, Erin B Kennedy, Pelin Cinar, et al.
Oncotarget|September 3, 2016
Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancyHaeseong Park, Ignacio Garrido-Laguna, Aung Naing, et al.
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
BMC Cancer|September 14, 2017
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancerKerry Lynn Reynolds, Philippe L Bedard, Se-Hoon Lee, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancerDung T Le, Gunnar Folprecht, Anna M Varghese, et al.
JCO Clinical Cancer Informatics|March 13, 2023
Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic AdenocarcinomaMatthew A Firpo, Kenneth M Boucher, Josh Bleicher, et al.
The New England Journal of Medicine|June 1, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic CancerEileen M O'Reilly, Zev A Wainberg, Andrew E Hendifar, et al.
Cancer|April 23, 2014
Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumorsDavid S Hong, Ignacio Garrido-Laguna, Suhendan Ekmekcioglu, et al.
Pageof 11